/XBI
XBI Stock - SPDR S&P Biotech ETF
Financial Services|Asset ManagementAMEX
$126.07+2.14%
+$2.64 (+2.14%) • Dec 22
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.99
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.65
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $138.68
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for XBI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$124.81 – $127.33
TARGET (TP)$144.98
STOP LOSS$115.98
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.38
52W High$126.49
52W Low$66.66
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Loading analyst ratings...
Earnings History & Surprises
XBILoading earnings data...
Frequently Asked Questions about XBI
What is XBI's current stock price?
SPDR S&P Biotech ETF (XBI) is currently trading at $126.07 per share. The stock has moved +2.14% today.
What is the analyst price target for XBI?
No analyst price targets are currently available for this stock.
What sector is SPDR S&P Biotech ETF in?
SPDR S&P Biotech ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is XBI's market cap?
SPDR S&P Biotech ETF has a market capitalization of $6.53 billion, making it a mid-cap company.
Does XBI pay dividends?
No, SPDR S&P Biotech ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAIQ
Global X Artificial Intelligence & Technology ETF
$51.16
Mkt Cap: $6.0B
BBIN
JPMorgan BetaBuilders International Equity ETF
$73.45
Mkt Cap: $6.0B
BBUS
JPMorgan BetaBuilders U.S. Equity ETF
$124.23
Mkt Cap: $6.6B
EWZ
iShares MSCI Brazil ETF
$30.98
Mkt Cap: $6.2B
FDL
First Trust Morningstar Dividend Leaders Index Fund
$44.24
Mkt Cap: $6.1B
IDV
iShares International Select Dividend ETF
$39.20
Mkt Cap: $6.3B
KBWB
Invesco KBW Bank ETF
$85.76
Mkt Cap: $5.6B
TCAF
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Capital Appreciation Equity ETF
$38.45
Mkt Cap: $6.3B
VOOV
Vanguard S&P 500 Value Index Fund
$205.91
Mkt Cap: $6.1B
XAR
SPDR S&P Aerospace & Defense ETF
$249.50
Mkt Cap: $4.7B
Explore stocks similar to XBI for comparison